Fatemeh Sarvi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fatemeh Sarvi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Afsaneh Ghorbani
Reproductive Sciences and Technology Research Center; Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran
1 shared publicationBehnam Khodadoust
Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
1 shared publication- Hamid Salehiniya
Department of Epidemiology and Biostatistics, School of Health, Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand 9717853577, Iran
1 shared publication - Ibrahim Alkatout
Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria
1 shared publication - Leila Allahqoli
Faculty of Health Sciences, Cyprus International University, Nicosia 99258, Cyprus
1 shared publication Mahmoud Khodadost
Department of Public Health, School of Health, Larestan University of Medical Sciences, Larestan, Iran
1 shared publication
Latest Publications
- Open Access
- 9 February 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Spatio-temporal analysis of tuberculosis prevalence in Iran
Iran has one of the highest tuberculosis (TB) incidence rates in the Middle East, but a comprehensive analysis of its spatiotemporal distribution is lackin
- 9 February 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessSpatio-temporal analysis of tuberculosis prevalence in Iran
Iran has one of the highest tuberculosis (TB) incidence rates in the Middle East, but a comprehensive analysis of its spatiotemporal distribution is lackin
- Open Access
- 15 May 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 25 (1) , 1-8
A non-randomized study of sexual health education on the sexual function of primigravid women
Sexual function is a particularly important aspect of pregnant women’s lives that can affect mental health and family cohesion. This study aimed to determine the effect of sexual health education on sexual function in primigravida women. In a non-randomized study, primigravida women were divided into an intervention group (n = 43) and a control group (n = 43). The intervention group participated in six 60-minute sex education sessions, while the control group received no intervention. Both groups were monitored for 8 weeks. Sexual function was evaluated using the Female Sexual Function Index (FSFI) questionnaire before the intervention, at 4 weeks, and at 8 weeks post-intervention. Ultimately, data from 80 patients were analyzed. The two groups did not differ significantly in terms of demographic and pre-intervention clinical characteristics. At the 4-week mark post-intervention, there was no statistically significant difference observed in the average score of the overall index of sexual performance between the pregnant women in the two groups. However, upon comparing sexual function before intervention and at 4 and 8 weeks after intervention, significant improvements were noted in desire, arousal, lubrication, orgasm, satisfaction, and pain subscale scores within the intervention group (p < 0.001). Conversely, in the control group, desire (psychological interest or motivation), arousal (physiological and emotional readiness), lubrication, and satisfaction subscale scores decreased, while the pain subscale score slightly increased between pre-intervention and the 8-week follow-up. The mean difference in the overall FSFI score before and 8 weeks after the intervention was notably higher in the intervention group (7.37 points) compared to the control group (-0.87 points (p < 0.001). The findings of this study highlight the transformative impact of sexual health education during pregnancy. By dispelling misconceptions and enriching knowledge, such interventions have the potential to enhance the sexual function of pregnant women significantly. These results underscore the effectiveness of integrating sexual health education into routine prenatal care, emphasizing its pivotal role in promoting the overall well-being of primiparous pregnant women. This study retrospectively registered with the Iranian Clinical of Trials Registry with IRCT registration number IRCT20090810002324N20 (08-04-2025) ( https://irct.behdasht.gov.ir/trial/82382 ).
- 15 May 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 25 (1) , 1-8
Open AccessA non-randomized study of sexual health education on the sexual function of primigravid women
Sexual function is a particularly important aspect of pregnant women’s lives that can affect mental health and family cohesion. This study aimed to determine the effect of sexual health education on sexual function in primigravida women. In a non-randomized study, primigravida women were divided into an intervention group (n = 43) and a control group (n = 43). The intervention group participated in six 60-minute sex education sessions, while the control group received no intervention. Both groups were monitored for 8 weeks. Sexual function was evaluated using the Female Sexual Function Index (FSFI) questionnaire before the intervention, at 4 weeks, and at 8 weeks post-intervention. Ultimately, data from 80 patients were analyzed. The two groups did not differ significantly in terms of demographic and pre-intervention clinical characteristics. At the 4-week mark post-intervention, there was no statistically significant difference observed in the average score of the overall index of sexual performance between the pregnant women in the two groups. However, upon comparing sexual function before intervention and at 4 and 8 weeks after intervention, significant improvements were noted in desire, arousal, lubrication, orgasm, satisfaction, and pain subscale scores within the intervention group (p < 0.001). Conversely, in the control group, desire (psychological interest or motivation), arousal (physiological and emotional readiness), lubrication, and satisfaction subscale scores decreased, while the pain subscale score slightly increased between pre-intervention and the 8-week follow-up. The mean difference in the overall FSFI score before and 8 weeks after the intervention was notably higher in the intervention group (7.37 points) compared to the control group (-0.87 points (p < 0.001). The findings of this study highlight the transformative impact of sexual health education during pregnancy. By dispelling misconceptions and enriching knowledge, such interventions have the potential to enhance the sexual function of pregnant women significantly. These results underscore the effectiveness of integrating sexual health education into routine prenatal care, emphasizing its pivotal role in promoting the overall well-being of primiparous pregnant women. This study retrospectively registered with the Iranian Clinical of Trials Registry with IRCT registration number IRCT20090810002324N20 (08-04-2025) ( https://irct.behdasht.gov.ir/trial/82382 ).
- 4 September 2024
- Published by Springer Nature in Current Cardiology Reports
- Vol. 26 (10) , 1113-1122
The Effect of Recurrent Heart Failure Hospitalizations on the Risk of Cardiovascular and all-Cause Mortality: a Systematic Review and Meta-Analysis
Introduction Heart failure (HF) is a significant worldwide concern due to its substantial impact on mortality rates and recurrent hospitalizations. The relationship between recurrent hospitalizations and mortality in individuals diagnosed with heart failure has been the subject of conflicting findings in previous studies. A meta-analysis was conducted to investigate the association between recurrent heart failure hospitalizations (HFHs) and mortality. Methods We conducted a systematic search across various online databases, such as PubMed, Embase, Web of Science, ProQuest, Scopus, Science Direct, and Google Scholar, to locate studies that examined the connection between recurrent HFHs and cardiovascular (CV) mortality as well as all-cause mortality until January 2023. To evaluate the heterogeneity among the studies, we employed I2 and Cochran’s Q test. Results In total, 143,867 participants from seven studies were included in the analysis. Recurrent HFHs were found to be strongly associated with elevated risks of both cardiovascular (CV) mortality and all-cause mortality. The pooled hazard ratios (HRs) indicated a non-significant association for CV mortality (HR = 4.28, 95% CI: 0.86–7.71) but a significant association for all-cause mortality (HR = 2.76, 95% CI: 2.05–3.48). Subgroup analyses revealed a reduction in heterogeneity when stratified by factors such as quality score, sample size, hypertension comorbidity, number of recurrent HFHs, and follow-up time. A clear correlation was observed between the frequency of HFH and the mortality risk. Various subgroups, including those with diabetes, atrial fibrillation, and chronic kidney disease, showed significant associations between recurrent HFHs and all-cause mortality. Additionally, recurrent HFHs were significantly associated with CV mortality in subgroups such as heart failure with reduced ejection fraction (HFrEF), atrial fibrillation, and diabetes. Conclusion This meta-analysis provides evidence of an association between recurrent HFH and elevated risk of both CV mortality and all-cause mortality. The findings consistently indicate that a higher frequency of HFH is strongly associated with an increased likelihood of mortality.
- 4 September 2024
- Published by Springer Nature in Current Cardiology Reports
- Vol. 26 (10) , 1113-1122
The Effect of Recurrent Heart Failure Hospitalizations on the Risk of Cardiovascular and all-Cause Mortality: a Systematic Review and Meta-Analysis
Introduction Heart failure (HF) is a significant worldwide concern due to its substantial impact on mortality rates and recurrent hospitalizations. The relationship between recurrent hospitalizations and mortality in individuals diagnosed with heart failure has been the subject of conflicting findings in previous studies. A meta-analysis was conducted to investigate the association between recurrent heart failure hospitalizations (HFHs) and mortality. Methods We conducted a systematic search across various online databases, such as PubMed, Embase, Web of Science, ProQuest, Scopus, Science Direct, and Google Scholar, to locate studies that examined the connection between recurrent HFHs and cardiovascular (CV) mortality as well as all-cause mortality until January 2023. To evaluate the heterogeneity among the studies, we employed I2 and Cochran’s Q test. Results In total, 143,867 participants from seven studies were included in the analysis. Recurrent HFHs were found to be strongly associated with elevated risks of both cardiovascular (CV) mortality and all-cause mortality. The pooled hazard ratios (HRs) indicated a non-significant association for CV mortality (HR = 4.28, 95% CI: 0.86–7.71) but a significant association for all-cause mortality (HR = 2.76, 95% CI: 2.05–3.48). Subgroup analyses revealed a reduction in heterogeneity when stratified by factors such as quality score, sample size, hypertension comorbidity, number of recurrent HFHs, and follow-up time. A clear correlation was observed between the frequency of HFH and the mortality risk. Various subgroups, including those with diabetes, atrial fibrillation, and chronic kidney disease, showed significant associations between recurrent HFHs and all-cause mortality. Additionally, recurrent HFHs were significantly associated with CV mortality in subgroups such as heart failure with reduced ejection fraction (HFrEF), atrial fibrillation, and diabetes. Conclusion This meta-analysis provides evidence of an association between recurrent HFH and elevated risk of both CV mortality and all-cause mortality. The findings consistently indicate that a higher frequency of HFH is strongly associated with an increased likelihood of mortality.